Mehrad Adibi, M.D.
Department of Urology, Division of Surgery
About Dr. Adibi
Dr. Adibi is a urologic oncologist and Associate Professor of Urology specializing in the surgical treatment of cancers of the genitourinary system. He earned his medical degree from the University of Texas Southwestern Medical Center in Dallas, where he also went on to complete an internship in general surgery and residency in Urology. After residency, he completed a two-year fellowship in Urologic Oncology at the University of Texas MD Anderson Cancer Center. Dr. Adibi also holds a master’s degree in Biomedical Engineering from the University of Texas at Arlington. He participated in a multitude of clinical research projects at MD Anderson and has numerous publications in peer-reviewed journals. He currently holds a faculty position as Associate Professor in the Department of Urology at MD Anderson. His clinical interests include the screening, diagnosis, and surgical treatment of the full spectrum of urologic cancers, including prostate, bladder, kidney, and other genitourinary cancers with expertise in open, minimally invasive, and robotic surgical approaches
Read More
Meet Mehrad Adibi, M.D.
Mehrad Adibi, M.D., explains how MD Anderson is different
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Adjunct Professor, Department of Surgical Oncology, Division of Urology, The University of Texas Medical Branch (UTMB), Galveston, TX
Education & Training
Degree-Granting Education
| 2008 | The University of Texas at Southwestern Medical Center, Dallas, TX, USA, MD, Medicine |
| 2004 | The University of Texas at Arlington, Arlington, TX, USA, MS, Biomedical Engineering |
| 2003 | The University of Texas at Arlington, Arlington, TX, USA, BS, Biology |
Postgraduate Training
| 2013-2014 | Fellowship, Urologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 2009-2013 | Residency, Urology, The University of Texas Southwestern Medical Center, Dallas, TX |
| 2008-2009 | General Surgery, Clinical Internship, The University of Texas Southwestern Medical Center, Dallas, TX |
Board Certifications
| 2018 | American Board of Urology |
Experience & Service
Administrative Appointments/Responsibilities
Educational Committee Member, Robotic Simulation and Educational Task Force, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Electronic Health Records Officer, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Assistant Residency Program Site Director, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Patient Experience Officer, Department of Urology, MD Anderson Cancer Center, LEAGUE CITY, TX, 2018 - Present
Member, Commission on Cancer Committee, Clear Lake Regional Medical Center, Webster, TX, 2017 - 2019
Other Appointments/Responsibilities
Member and Interviewer, UT Health, Houston, TX, 2018 - Present
Faculty Advisor, Innovation Institute, Houston, TX, 2017 - Present
Institutional Committee Activities
Committee Member, Division of Surgery Educational (DoSED), 2020 - Present
Alternate member to John Papadopoulos, Credentialing Committee for Medical Staff (CCMS), 2020 - Present
Member and Urology Department Representative, ACGME UT Houston Urology Residency Improvement Task Force, 2019 - Present
GU Clinical Trials Liasion, Houston Area Location Research Steering Committee, 2019 - Present
Member, Faculty Academic Review Committee, 2018 - Present
Member and Urology Department Representative, Value Analysis Team Committee, Perioperative Services, 2017 - Present
Faculty Member, Patient Experience Committee, MD Anderson League City, 2017 - Present
Honors & Awards
| 2018 | Recipient of Fellows Faculty Teaching Award, MD Anderson Cancer Center |
| 2017 | Top 1% of Physicians Across the Nation for Patient Satisfaction Award, CG CAHPS Survey |
| 2008 | Honors earned in Surgery, Medicine, University of Texas Southwestern Medical School |
| 2004 | Alfred & Janet Potvin Award for Outstanding Biomedical Engineering Student at M.S. Level, University of Texas at Arlington Graduate School of Engineering |
| 2004 | Alumni Scholarship, University of Texas Southwestern |
| 2004 | Exemplary Achievement in Academics/Research, University of Texas at Arlington Department of Engineering |
| 2003 | Bachelor of Sciences with Distinction, The University of Texas at Arlington |
| 2000 | Dean's Honor List, The University of Texas at Arlington |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Adibi M, McCormick B, Economides MP, Petros F, Xiao L, Guo C, Shah A, Kamat AM, Dinney C, Navai N, Gao J, Siefker-Radtke A, Matin SF, Campbell MT. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer 20(2):176-182, 2022. e-Pub 2021. PMID: 35039231.
- Kokorovic A, Duplisea J, Qiao W, McCormick B, Adibi M, Papadopoulos J, Ramirez G, Rao P, Tamboli P, Pettaway C. Oncologic outcomes and subsequent treatment following organ sparing surgery for penile carcinoma: The University of Texas M.D. Anderson Cancer Center Experience. Urol Oncol 39(5):302.e19-302.e27, 2021. e-Pub 2021. PMID: 33612354.
- Kleinmann N, Matin SF, Pierorazio PM, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky S, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Stern J, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Adibi M, Amin MB, Seltzer E, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Schoenberg M, Lerner SP. Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial. Lancet Oncol 21(6):776-785, 2020. e-Pub 2020. PMID: 32631491.
- Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Aboshady YI, Abel EJ, Matin SF, Karam JA, Wood CG. Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy. Eur Urol Focus(PMID31685445). e-Pub 2019. PMID: 31685445.
- Wood EL, Adibi M, Qiao W, Brandt J, Zhang M, Tamboli P, Matin SF, Wood CG, Karam JA. Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses. J Urol 199(2):393-400, 2018. e-Pub 2017. PMID: 28941919.
- Thomas AZ, Adibi M, Slack RS, Borregales LD, Merrill MM, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. The role of metastasectomy in patients with renal cell carcinoma with sarcomatoid dedifferentiation: a matched controlled analysis. J Urol 196(3):678-84, 2016. e-Pub 2016. PMID: 27036304.
- Cost NG, Caldwell BT, Adibi M, Raj GV, Sagalowsky AI, Margulis V. Do referral patterns in adolescents and young adults with testicular cancer impact oncologic outcomes?. J Adolesc Young Adult Oncol 5(3):248-53, 2016. e-Pub 2016. PMID: 26871870.
- Borregales LD, Kim DY, Staller AL, Qiao W, Thomas AZ, Adibi M, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy. Urol Oncol 34(5):237.e19-26, 2016. e-Pub 2015. PMID: 26707613.
- Borregales LD, Adibi M, Thomas AZ, Wood CG, Karam JA. The role of neoadjuvant therapy in the management of locally advanced renal cell carcinoma. Ther Adv Urol 8(2):130-41, 2016. e-Pub 2015. PMID: 27034725.
- Adibi M, Kenney PA, Thomas AZ, Borregales LD, Nogueras-González GM, Wang X, Devine CE, Karam JA, Wood CG. Prediction of pulmonary metastasis in renal cell carcinoma patients with indeterminate pulmonary nodules. Eur Urol 69(2):352-60, 2016. e-Pub 2015. PMID: 26382085.
- Adibi M, Thomas AZ, Borregales LD, Matin SF, Wood CG, Karam JA. Surgical considerations for patients with metastatic renal cell carcinoma. Urol Oncol 33(12):528-37, 2015. e-Pub 2015. PMID: 26546481.
- Adibi M, Thomas AZ, Borregales LD, Merrill MM, Slack RS, Chen HC, Sircar K, Murugan P, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation. Urol Oncol 33(10):427.e17-23, 2015. e-Pub 2015. PMID: 26004164.
- Thomas AZ, Adibi M, Borregales LD, Wood CG, Karam JA. Role of metastasectomy in metastatic renal cell carcinoma. Curr Opin Urol 25(5):381-9, 2015. PMID: 26125508.
- Thomas AZ, Adibi M, Borregales LD, Hoang LN, Tamboli P, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy. J Urol 194(2):316-22, 2015. e-Pub 2015. PMID: 25758610.
- Thomas AZ, Adibi M, Borregales LD, Karam JA, Wood CG. Cytoreductive surgery in the era of targeted molecular therapy. Transl Androl Urol 4(3):301-9, 2015. PMID: 26815334.
- Adibi M, Karam JA, Wood CG. Reporting geographic and temporal trends in renal cell carcinoma: why is this important?. Eur Urol 67(3):531-2, 2015. e-Pub 2014. PMID: 25454608.
- Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI, Margulis V. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors. J Urol 191(5 Suppl):1485-90, 2014. e-Pub 2014. PMID: 24679874.
- Cost NG, Lubahn JD, Adibi M, Romman A, Wickiser JE, Raj GV, Sagalowsky AI, Margulis V. A comparison of pediatric, adolescent, and adult testicular germ cell malignancy. Pediatr Blood Cancer 61(3):446-51, 2014. e-Pub 2013. PMID: 24106160.
- Seideman CA, Zhao LC, Hudak SJ, Mierzwiak J, Adibi M, Morey AF. Is prolonged catheterization a risk factor for artificial urinary sphincter cuff erosion?. Urology 82(4):943-6, 2013. PMID: 24074987.
- Hudak SJ, Morey AF,Adibi M, Bagrodia A. Favorable patient reported outcomes after penile plication for wide array of peyronie disease abnormalities. J Urol 189(3):1019-24, 2013. e-Pub 2012. PMID: 23017514.
- Olweny EO, Kapur P, Tan YK, Park SK, Adibi M, Cadeddu JA. Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney. Urology 81(3):679-84, 2013. e-Pub 2013. PMID: 23290141.
- Adibi M, Hornberger B, Bhat D, Raj G, Roehrborn CG, Lotan Y. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol 189(2):535-40, 2013. e-Pub 2012. PMID: 22982426.
- Adibi M, Youssef R, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Montorsi F, Bolenz C, Margulis V. Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades. Int J Urol 19(12):1060-6, 2012. e-Pub 2012. PMID: 22882743.
- Cost NG, Adibi M, Lubahn JD, Romman A, Raj GV, Sagalowsky AI, Margulis V. Effect of testicular germ cell tumor therapy on renal function. Urology 80(3):641-8, 2012. e-Pub 2012. PMID: 22840865.
- Adibi M, Pearle MS, Lotan Y. Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis. BJU Int 110(2 Pt 2):E86-91, 2012. e-Pub 2011. PMID: 22115356.
- Adibi M, Hudak SJ, Morey AF. Penile plication without degloving enables effective correction of complex Peyronie's deformities. Urology 79(4):831-5, 2012. e-Pub 2012. PMID: 22365444.
- Puerto Souza GA, Adibi M, Cadeddu JA, Mariottini GL. Adaptive Multi-Affine (AMA) feature-matching algorithm and its application to minimally-invasive surgery images. Intelligent Robots and Systems (IROS):2371-2376, 2011. e-Pub 2011.
- Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 179(1):75-9; discussion 79-80, 2008. e-Pub 2007. PMID: 17997440.
Invited Articles
- Thomas AZ, Adibi M, Borregales LD, Karam JA, Wood CG. Cytoreductive surgery in the era of targeted molecular therapy. Transl Androl Urol 4(3):301-9, 2015. PMID: 26815334.
- Adibi M, Karam JA, Wood CG. Reporting geographic and temporal trends in renal cell carcinoma: why is this important?. Eur Urol 67(3):531-2, 2015. e-Pub 2014. PMID: 25454608.
Manuals, Teaching Aids, Other Teaching Publications
- Jason Au, MD (UT Houston), Mehrad Adibi, MD (MD Anderson), Philip Mann, MD (UT Houston). UT Houston Urology Residency Robotic Training Curriculum, 2021.
- Mehrad Adibi, Reena Cherry. Rotating Residents On-Boarding and Orientation Handbook, Department of Urology Rotation, MD Anderson Cancer Center, 2019.
Editorials
- Labbate CV, Adibi M, Matin SF. Editorial Comment. J Urol 207(6):1309-1310, 2022. PMID: 35236102.
- Adibi M, Matin SF. Endoscopic Treatment for Large Upper Tract Urothelial Carcinoma. J Urol 205(4):1046, 2021. PMID: 33476195.
- Lotan Y, Adibi M, Pearle MS. Reply. BJU Int 109(8):E26-7, 2012. PMID: 22455405.
Abstracts
- Andrew JR, Ranasinghe, Zhang M Elsheshtawi, Adibi M, Chery L, Gregg JR, Papadopoulos JN, Pettaway CA, Pisters L, Ward JF, Davis JW, Chapin BF, Troncoso P, Bathala T. Can MRI be used to guide nerve spare and lymph node dissection in men undergoing radical prostatectomy for the highly aggressive ductal adenocarcinoma of the prostate?. SUO, 2021.
- Kokorovic A,Duplisea J,Wei Q,Adibi M,Papadopoulos JN, Ramirez G,Tamboli P,Rao P,Pettaway C,. Organ Sparing Surgery (Oss) For Localized Penile Cancer: Long-Term Results. AUA 2019, 2019.
- Kokorovic A,Duplisea J, Wei Q,McCOrmick B,Adibi M,Papadopoulos JN,Ramirez G,Tamboli P,Rao P,Pettaway C,. Oncologic outcomes of organ sparing surgery for localized penile cancer: The MD Anderson Cancer Center Experience. SUO 2019, 2019.
- Brian F. Chapin,Xuemei Wang,Mohamed Elsheshtawi,Miao Zhang,Paul Corn,Amado J. Zurita,John W. Davis, Curtis Pettaway,Mehrad Adibi, Martin Gleave, Mathew Cooperberg, Marc Smaldone, Sean McGuire, Shi-Ming Tu, Jennifer Wang, Sumit Subudhi, Eleni Efsthatiou, Christopher J. Logothetis, Patricia Troncoso, Ana Aparicio,. Complex Biologic Heterogeneity of de novo hormone naive metastatic prostate cancer (HNPCa)comparison of early progessors and prolonged responders to initial systemic treatment. ASCO-GU 2019, 2019.
- Ana Aparicio,Miao Zhang,Naveen Ramesh,Xuemei Wang,Paul Gettys Corn,Amado J. Zurita,John W. Davis,Curtis Alvin Pettaway,Mehrad Adibi, Sean Eric McGuire, Shi-Ming Tu, Jennifer Wang,Sumit Kumar Subudhi,Mohamed A. Elsheshtawi,Eleni Efsthaiou, Christopher Logothetis, Nicholas Navin, Patricia Troncoso, Brian Chapin. Aggressive variant prostate cancer (AVPC) molecular signature in castration-sensitive, de novo metastatic prostate cancer (M1PCa). ASCO-GU2019, 2019.
- Thomas AZ, Adibi M, Slack R, Borregales LD, Merrill MM, Tamboli P, Sircar K, Jonasch E, Tannir NM, Matin SF, Wood CG, Karam JA. The role of metastasectomy in patients with renal cell carcinoma with sarcomatoid dedifferentiation: A matched controlled analysis. ASCO-J Clin Oncol 34(suppl 2S), 2016.
- Borregales LD, Adibi M, Thomas AZ, Reis RB, Chery LJ, Devine CE, Wang X, Potretzke AM, Potretzke T, Figenshau RS, Bauman TM, Matin SF, Karam JA, Wood CG. Predicting adherent perinephric fat with preoperative clinical and radiological factors in partial nephrectomy: Development and validation of a risk score. ASCO-J Clin Oncol 34(suppl 2S), 2016.
- Adibi M, Arun Thomas Z, Borregales L, Merrill MM, Sircar K, Tamboli P, Slack R, Chen HC, Tannir NM, Jonasch E, Matin SF, Wood CG, Karam JA. Percentage of sarcomatoid component as a prognostic indicator for survival in sarcomatoid renal cell carcinoma. ASCO-J Clin Oncol 33(suppl 7), 2015.
- Adibi M, Kenney P, Thomas AZ, Devine C, Karam JA, Wood CG. Predicting pulmonary metastases among renal cell carcinoma patients with indeterminate pulmonary nodules. ASCO-J Clin Oncol 33(suppl 7), 2015.
- Thomas AZ, Adibi M, Borregales L, Hoang LN, Tamboli P, Matin SF, Karam JA, Wood CG. Surgical management for local retroperitoneal recurrence after radical nephrectomy in the targeted therapy era. ASCO-J Clin Oncol 33(suppl 7), 2015.
- Adibi M,Thomas AZ, Borregales LD, Sircar K, Slack R, Chen HC, Wood CG, Karam J. Percentage of sarcomatoid component as a prognostic indicator for survival in sarcomatoid renal cell carcinoma. SUO, 2014.
- Adibi M, Kenney P Thomas AZ, Devine C, Karam JA, Wood CG. Predicting pulmonary metastases among renal cell carcinoma patients with indeterminate pulmonary nodules. SUO, 2014.
- Adibi M, Lotan Y. Reduction in hospital admission rates due To post−prostate biopsy infections after augmenting standard antibiotic prophylaxis. AUA, 2012.
- Lubahn J, Cost N, Adibi M, Romman A, Margulis V. A novel risk stratification system For chemotherapy failure in testicular germ cell tumor (T-GCT). SUO, 2011.
- Adibi M, Pearle MS, Lotan Y. Cost−effectiveness of standard versus intensive antibiotic regimens for trans−rectal ultrasound guided prostate biopsy prophylaxis. SCS AUA, 2011.
- Adibi M, Hudak SJ, Morey AF. The use of minimally invasive penoscrotal plication for treatment of biplanar and complex peyronie’s disease. SCS AUA, 2011.
- Adibi M, Youssef R, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Langner C,. Comparison of outcomes of definitive therapy for upper tract urothelial carcinoma over three decades. SCS AUA, 2011.
- Seideman C, Adibi M, Mierzwiak J, Hudak SJ, Morey AF. Urethral catheterization is a major risk factor for artificial urinary sphincter cuff erosion. SCS AUA, 2011.
- Puerto G, Adibi M, Cadeddu JA, Mariottini GL. Adaptive multi-affine (AMA) feature - matching algorithm and its application to minimally-invasive surgery images. IEEE/RSJ International Conference, 2011.
- Adibi M, Cost N, Lubahn J, Romman A, Margulis V. Novel predictors of benign pathology in stage Ia Or Ib patients with non seminomatous testicular germ cell malignancy undergoing primary retroperitoneal lymph-node dissection. SUO, 2011.
- Cost N, Adibi M, Lubahn J, Romman A, Raj GV, Sagalowsky AI, Margulis, V. The impact of surgical or systemic therapy for testicular germ cell malignancy on renal function. SUO, 2011.
- Moses KA, Adibi M, Petros JA, Issa MM, Ritenour CWM. First time urolithiasis in patients greater than 75 years of age. SES AUA, 2008.
- Gupta A, Zeltser IS, Adibi M, Bensalah K, Cadeddu JA, Lotan Y. Does renal radio frequency ablation (RFA) result in development of postoperative fever and flu-like symptoms. AUA, 2008.
- Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA. Raj GV renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. AUA, 2008.
- Adibi M, Bohluli P, Nwariaku F. Drug-eluting, antibody-conjugated canoparticles targeting. Graduate Student Symposium, 2004.
Book Chapters
- Adibi Mb, Dinney CP. Treatment Paradigms in Bladder Cancer: Clinical Implications of Histological and Molecular Analysis. In: Precision Molecular Pathology of Bladder Cancer. Springer, 2018.
Letters to the Editor
- Adibi M, Karam JA, Wood CG. Reporting geographic and temporal trends in renal cell carcinoma: why is this important?. Eur Urol 67: 531-2, 2015.
Patient Reviews
CV information above last modified December 01, 2023